Nonalcoholic fatty liver disease (NAFLD) is considered as the hepatic manifestation of the metabolic syndrome. In the majority of patients, NAFLD is associated with metabolic risk factors such as obesity, insulin resistance and dyslipidemia. Early stages of NAFLD are histologically categorized into simple steatosis and nonalcoholic steatohepatitis (NASH). Simple steatosis is defined as the presence of hepatic steatosis with no evidence of further hepatocellular injury (eg, ballooning of the hepatocytes). NASH is defined as the presence of hepatic steatosis and inflammation with hepatocellular injury. NASH may progress to fibrosis, cirrhosis and hepatocellular carcinoma. 1 The prevalence of NAFLD in Western society is 20-30% and particularly because of a sedentary lifestyle and overnutrition, its incidence is still rising. In addition to the quantity of consumed calories, certain nutrients and food compounds have profound effects on development and/or progression of NAFLD. 2 Pure high-fat diets result in hepatic steatosis as well as obesity and insulin resistance in rodents, but do not reliably induce significant hepatic inflammation and fibrosis. 3 In addition to the amount, also the type of fat critically affects NAFLD progression. Fat predominantly composed of saturated fatty acids, which are frequent in Western diets, exhibits more adverse health effects than fat types with a higher amount of mono-or polyunsaturated fatty acids. 4 Further, also cholesterol has a crucial role in NASH development. 5 As reviewed by Farrell et al 5 , free cholesterol accumulation in the liver is one of the few reliable factors, which discriminate steatohepatitis from simple fatty liver. In addition to lipids, also the impact of fructose on NAFLD development and progression gets increasing attention. 2, 6 Fructose is mainly consumed with added sugars (sucrose and high fructose corn syrup), and represents up to 10% of the total energy intake in Western countries. 6 Fructose consumption induces insulin resistance and hepatic steatosis as well as steatohepatitis in rodents, and epidemiological studies revealed an association between fructose intake and NAFLD development and progression in men. 7 The aim of this study was to establish a dietary murine NASH model, which closely mimics the nutritional situation of NAFLD patients in Western countries. We applied a diet enriched with sucrose, cholesterol and a high concentration of fats, rich in saturated fatty acids in a composition, which mimics Western food. Feeding of this diet caused obesity, insulin resistance and significant hepatic steatosis, inflammation and fibrosis in mice. The mouse model faithfully reproduced most alterations of hepatic gene expression that were previously observed in humans. Surprisingly, we found enhanced c-Jun levels, and this observation was confirmed in human tissues, too. The activity of c-Jun N-terminal kinases (JNKs) and herewith c-Jun activation have been implicated in NASH progression, 8, 9 but abundance of c-Jun in NAFLD has not been describe before.
MATERIALS AND METHODS Animals and Dietary Model of NASH
Male C57BL/6N mice were purchased from Charles River Laboratories (Sulzfeld, Germany) at 12 weeks of age and housed in a 22 1C controlled room under a 12-h light-dark cycle with free access to food and water. After 2 weeks of acclimatization, mice were fed either with standard diet (control) or a NASH-inducing diet (ND), enriched with pork lard (15%), beef tallow (15%), palmitic acid (4%), stearic acid (4%), cholesterol (0.2%) and sucrose (30%). Both chows were prepared by Ssniff (Soest, Germany). After 12 weeks of feeding, animals were killed by heart puncture under deep ketamine/xylazine anesthesia, and blood samples and liver tissues were collected for further analyses. All procedures followed the University Regensburg guidelines for the care and use of laboratory animals.
Quantification of Serum Adipokines
Adipokines in murin serum samples were measured by enzyme-linked immunosorbent assay (ELISA) analysis using the adiponectin and leptin DuoSet ELISA Development kits from R&D Systems (Minneapolis, MN, USA) according to the manufacturer's instructions.
Glucose Tolerance Test
After 12-h fasting, mice were injected intraperitoneally with glucose (50% w/v solution, 6 ml/kg body weight). Blood glucose concentrations were measured in samples taken from the tail vein before and 15, 30, 60 and 90 min after glucose administration using an accutrend glucometer (Roche, Mannheim, Germany). For quantitative evaluation of the blood glucose curve, the area under the curve was determined.
Western Blotting
Protein extraction and western blotting analysis were performed as described 10 applying anti-rabbit antibodies against phospho-AKT (#4058), AKT (#9272), phospho-p65 (#3033), phospho-JNK (#9251), c-Jun (#9165) or phospho-c-Jun (#3270), all from Cell Signaling Technology (Danvers, MA, USA; all diluted 1:1000). Furthermore, antibodies against alpha smooth muscle actin (a-SMA) (ab5694 from Abcam, Cambridge, UK; 1:1000) or actin (MAB1501 from Merck Millipore, Billerica, MA, USA; 1:500) were applied.
Quantification of Hepatic Lipids
Hepatic lipids were extracted using the method of Bligh and Dyer with slight modifications. 11 Hepatic triglyceride, free fatty acid (FFA) and cholesterol levels were quantified using the GPO-triglyceride kit (Sigma, Deisenhofen, Germany), the cholesterol/cholesteryl ester quantification kit (BioVision, Mountain View, CA, USA) and the FFAs half micro test (Roche), respectively, as described. 12, 13 Quantitative Real-Time-PCR Analysis RNA isolation from liver tissue and reverse transcription were performed as described. 14 
Hepatic Hydroxyproline Content
Hepatic hydroxyproline content was quantified as described previously. 13 Briefly, liver tissues (200 mg) were hydrolyzed in 6 M HCl at 110 1C for 16 h. In all, 50 ml of each sample were incubated with chloramine T (2.5 mM) for 5 min and Ehrlich's reagent (410 mM) for 30 min at 60 1C. Absorption was measured in triplicates at 560 nm.
Immunohistological Analysis
For immunohistological analysis, tissue sections (5 mm) of paraffin-embedded tissue specimens were deparaffinized with xylene and stained as described previously 10 applying the following antibodies: anti-cJun (#9165), anti-phospho-cJun 
Microarray Gene Expression Analysis
The Mouse Gene 1.1 ST array from Affymetrix (Affymetrix, High Wycombe, UK) was used to assess transcriptome-wide expression profiles of four mice fed with the ND and four mice fed with regular diet. Microarrays were hybridized and scanned following the standard protocol of the Center for Fluorescent Bioanalytics (KFB; Regensburg, Germany). Normalization of raw intensity values from CEL files was performed using variance stabilization, 15 and the median polish was used to summarize individual probes to one relative expression level per gene. Genes were defined using a custom chip description file based on entrez gene identifiers (version 13.0.0). 16 Raw intensities and normalized gene expression data were publicly available at the NCBI Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/ geo/) under accession GSE52748. Differential gene expression between ND-fed and control mice was estimated using limma. 17 Microarray weights according to Ritchie 18 were applied for analysis of differential gene expression, giving higher weights to microarrays, which better fit the linear model for individual genes. Genes with a false discovery rate (FDR) below 0.01 were considered highly significant differentially expressed and genes with an FDR o0.05 were considered significant differentially expressed. FDR values are denoted as q-values in the text. All analyses were performed within the statistical programming environment R 19 and using Bioconductor packages. 20 Gene Set Analysis and Network Analysis Gene Set Analysis was performed using the hypergeometric test within the Bioconductor package HTSanalyzeR. 21 Genes meeting the FDR threshold of 0.01 were selected for testing significant enrichment of Gene Ontology (GO) terms. 22 To search for over-represented transcription factor target sites among the highly significant differentially expressed genes, mouse genes were first mapped to human genes using the homology mapping from NCBI (http://www.ncbi.nlm. nih.gov/projects/homology/maps) and then the transcription factor-binding sites collection from the MSigDB database (collection C3, transcription factor targets) was used for hypergeometric testing within HTSanalyzeR. 23 For both GO term and transcription factor-binding site enrichment, terms and binding sites with an FDRo0.05 were considered significant. Motives that cannot be assigned to any known transcription factor were excluded.
To integrate differentially expressed genes with proteinprotein interactions, the Bioconductor package BioNet was used. 24 Mouse gene symbols were mapped to human gene symbols as before to allow using the human interactome from the BioGRID data base. 25 BioNet was then used to find the highest-scoring protein-protein interaction subnetwork from the significant differentially expressed genes with an absolute log2 fold change larger than 0.5.
Human Tissues and Tissue Microarray (TMA)
A TMA was constructed out of 110 paraffin-embedded human hepatic tissue specimens with different degree of steatosis and inflammation. 26 All cases were reviewed by a surgical pathologist (AH). A modified histological NAFLD/ NASH score according to the recommendations of the Nonalcoholic Steatohepatitis Clinical Research Network was used. 27 Briefly, four histological features were evaluated semiquantitatively: steatosis (0-3), lobular inflammation (0-3) and hepatocellular ballooning (0-2). Steatohepatitis was diagnosed when the sum of the scores was 4 or more.
In addition to formalin-fixed liver tissue for TMA construction, 24 liver specimens, which had been immediately snap frozen after surgical resection and stored at À 80 1C, were available.
Human liver tissue was obtained and experimental procedures were performed according to the guidelines of the charitable state controlled foundation HTCR, with the informed patients' consent, and the study was approved by the local ethics committee of the University Regensburg.
Cells, Cell Culture and In Vitro Experiments
Primary human hepatocytes (PHHs) and hepatoma cell lines HepG2 (ATCC HB-8065) and Hep3B (ATCC HB-8064) were isolated and/or cultured as described previously. 28, 29 Under the same conditions, cells were stimulated with indicated concentrations of the FFA palmitic acid for 24 h using a specifically prepared palmitic acid/bovine serum albumin (BSA) stock solution. Preparation of the palmitic acid/BSA stock solution was carried out as described previously. 30 Briefly, a 100 mM palmitic acid stock solution (Cat#P0500; Sigma) was prepared in 0.1 mM NaOH by heating at 70 1C. 
Statistical Analysis
Statistical analysis of all other experiments besides the microarray data was performed as follows: values are presented as mean±s.e.m. Comparison between groups was made c-Jun in NAFLD C Dorn et al using the Student's unpaired t-test. Welch's correction was performed if required. Contingency table analysis and the two-sided Fisher's exact test were used to study the statistical association between clinicopathological and immunohistochemical variables. A P-value o0.05 was considered statistically significant. Calculations were performed using SPSS version 10.0 (SPSS, Chicago, IL, USA) and GraphPad Prism Software (GraphPad Software, Inc., San Diego, CA, USA).
RESULTS

Effect of the ND on Obesity and Other Elements of the Metabolic Syndrome
Feeding the ND led to significant body weight gain over time (Figure 1a ), and after 12 weeks ND-fed mice appeared obese and showed a marked enlargement of both visceral and subcutaneous white adipose tissue compared with mice fed with standard control chow ( Figure 1b ). Serum concentration of leptin was significantly elevated, whereas adiponectin levels were moderately decreased in ND-fed compared with control mice (Figure 1c ) mimicking an adipokine serum profile associated with obesity in humans. 31 Furthermore, fasting blood glucose levels were elevated (Figure 1d ), whereas glucose tolerance was impaired in ND-fed mice (Figure 1e ) pointing to manifest insulin resistance. In line with this, decreased hepatic AKT phosphorylation in ND-fed mice compared with control mice (Figure 1f ) indicated an impaired insulin response, a key pathological factor for NAFLD development and progression also in patients. 32 Effect of the ND on Hepatic Lipid Metabolism and Oxidative Stress ND-fed mice revealed remarkable hepatomegaly ( Figure 2a ) and a significantly increased liver to body weight ratio compared with control mice (7.5±1.5% vs 5.0±0.47%; P ¼ 0.02). , and assessment of hepatic triglycerides confirmed significantly elevated levels in ND-fed mice (956 ± 117 vs 24 ± 11 mg/g protein; Po0.001). Histological analysis showed mixed micro-and macrovesicular steatosis (Figure 2b ). Quantitative qPCR analysis revealed distinct alterations of the expression of several genes known to have a critical role in hepatic lipid metabolism in response to ND-feeding (Table 1 ) similar to pathological changes observed in NASH patients. Thus, the ND-diet induced a marked increase of expression of genes encoding proteins responsible for FFA uptake, binding and transport (Cd36, Fabp1), whereas the expression of genes involved in FA (de novo) synthesis (Acaca, Fasn, Scd1) were only slightly increased. These findings are similar as described in NASH patients 26, 33 and indicate that significantly higher FFA levels in ND-fed mice compared with control mice (31.4 ± 2.7 vs 23.9 ± 2.4 mEq/g protein; P ¼ 0.007) are mainly caused by enhanced hepatic FFA uptake. Similar to human NASH, 34 ND-feeding lead to a significant upregulation of expression of genes involved in mitochondrial (Acadl, Cpt1), peroxisomal (Acox1) and microsomal (Cyp2e1, Cyp4a10) FFA oxidation, which are known to cause increased reactive oxygen species (ROS) formation. Accordingly, a marked increase of hepatic Nrf2, Hmox1 and Nqo1 expression levels was detected in ND-fed mice (Figure 2c ), which depicts an endogenous defense mechanism to oxidative stress. In accordance, immunohistochemical analysis for proteins conjugated with the reactive aldehyde 4-hydroxynonenal demonstrate ongoing processes of lipid peroxidation (Figure 2d ). Peroxisome proliferatoractivated receptor alpha is a strong regulator of hepatic energy combustion, while PPARg has been shown to induce lipid synthesis and storage. Expression of both transcription factors was enhanced in ND-fed mice (Figure 2e ) similar as described in human NASH 35 indicative for a marked activation of the overall hepatic lipid metabolism. It is increasingly recognized that also cholesterol accumulation in the liver has a role in the progression of NASH, 5 and coherent with dietary cholesterol supplementation we found elevated hepatic cholesterol levels in ND-fed mice (21.1 ± 4.9 vs 11.6 ± 1.0 mg/g protein; P ¼ 0.01). In contrast, expression of genes involved in cholesterol de novo synthesis (Hmgcr, Cyp51) was reduced, whereas genes of cholesterol efflux (Abcg1, Abcg5, Abcg8) where slightly increased in livers of ND-fed mice ( Table 1) . Transcription of genes responsible for cholesterol conversion (into bile acids; Cyp7a1) or bile acid transportation (Abcb11, Slc10a1) was not significantly altered (Table 1 ). 36, 37 which are also present in patients with NASH. 38 Also ND-fed mice showed increased alanine aminotransferase serum levels (122±41 vs 41±6 U/l; P ¼ 0.01) and elevated hepatocellular caspase-3 activity (Figure 3a ) compared with control-fed mice. Increased hepatocellular damage was paralleled by increased regenerative proliferation as shown by an increase of Ki67-positive nuclei (Figure 3b ) and increased hepatic cyclin D1 expression (Figure 3c ). Furthermore, NDfeeding markedly induced expression of proinflammatory cytokines and chemokines (Figure 3e ), as well as hepatic infiltration by inflammatory cells (Figure 3d ). Elevated expression of NADPH oxidase complex genes, namely Ncf1, Cyba and Cybb, indicated high activity of macrophages and neutrophils in livers of ND-fed mice (Figure 3f ), which presumably contributes to the observed increase of oxidative stress because of NADPH oxidase-mediated ROS formation. Oxidative stress is a strong inducer of the NFkB pathway, a regulator of proinflammatory gene expression and critical factor for the progression from simple steatosis to NASH. In line with this and similar as described in NASH patients, 39 elevated levels of phosphorylated p65 indicated increased NFkB activation in the livers of ND-fed mice (Figure 3g ). In accordance, NFkB target genes such as ICAM-1 and survivin were significantly higher in parenchymal and non-parenchymal liver cells isolated from ND-fed mice compared with cells from control mice (Supplementary Figure 1) .
Effect of the ND on Hepatic Fibrosis
Sustained hepatic injury and inflammation lead to the activation of hepatic stellate cells (HSCs), a key event of hepatic fibrosis. Also ND-fed mice revealed significantly heightened mRNA and protein levels of hepatic a-SMA, an established marker of activated HSC (Figures 4a-c) . 40 This was accompanied by a distinct profibrogenic transcriptional profile, characterized by significantly elevated hepatic levels of transforming growth factor beta (Tgf-b), tissue inhibitor of metalloproteases-1 (Timp-1) and plasminogen activator inhibitor-1 (Pai-1; Figure 4d ), profibrogenic genes highly expressed in activated HSC. 41 Accordingly, collagen type I (Coll-I) gene transcription was elevated (Figure 4d ), resulting in increased hydroxyproline levels (Figure 4e ) and extracellular matrix deposition (Figure 4f ) in livers of ND-fed mice.
Systemic Characterization of the Altered Hepatic Gene Expression Caused by Feeding the ND
To further characterize this novel NASH model, we performed a transcriptome-wide gene expression analysis. Hepatic expression levels of ND-fed mice were compared with expression levels of mice fed with regular diet. Analysis of a total of 19 776 genes revealed significant (qo0.05) upregulation of 2305 genes (thereof 1030 highly significant; qo0.01) and significant downregulation of 713 genes (thereof 252 highly significant) in livers of ND-fed mice compared with control mice (Figure 5a ). Classification of the highly significant differentially expressed genes in GO categories 22 of biological processes showed significant over-representation of genes involved in metabolic and transport processes (Figure 5b ). Also numerous genes related to signal transduction and transcriptional regulation as well as oxidation reduction processes were differentially expressed in ND-fed mice. Notably, among the 25 largest GO categories belonging to the biological processes branch, the categories 'cell adhesion', 'lipid metabolic process' , 'innate immune response' and 'inflammatory response' carried significantly more differentially expressed genes than what would be expected by chance. Although alterations of 'lipid metabolic processes' reflect the dysregulated hepatic lipid metabolism, changes in the categories 'innate immune response' and 'inflammatory response' point to constant inflammatory processes in dietinduced NASH livers.
Effect of ND on c-Jun Expression
To identify possibly involved transcription factors responsible for the observed expressional alterations after ND feeding, we searched for over-represented transcription factor target sites among the differentially expressed genes. Mouse genes were first mapped to human genes using the homology mapping from NCBI (http://www.ncbi.nlm.nih.gov/projects/homology/ maps). Then, the transcription factor-binding sites collection from the MSigDB database (collection C3, transcription factor targets) 23 was used for hypergeometric testing within HTSanalyzeR. For both GO term and transcription factorbinding site enrichment, terms and binding sites with an FDR o0.05 were considered significant. Activator protein-1 (AP-1) binding sites were found to be significantly overrepresented within the regulated genes (Table 2) indicating AP-1 as the most likely transcription factor to cause the transcriptional changes. Furthermore, we looked for genes dysregulated in ND-fed mice, which interact on the protein level. Combining differentially expressed genes with a protein-protein interaction network, we searched for the largest connected dysregulated sub-network. Focusing on genes with an absolute log2-fold change of at least 0.5, we found a network of 23 connected genes, of which 22 were upregulated in ND-fed mice and one was repressed (Figure 6a) . Interestingly, c-Jun (a component of the AP-1 complex) is a hub in this network, connecting other (transcription) factors, some of which have already been shown to be implicated in NASH development and progression. 42, 43 ND-fed mice showed significantly higher hepatic JNK activity (Figure 6b ) and c-Jun-phosphorylation (Ser73) (Figure 6c (Figure 6e ; lower panel). Increased JNK activity and subsequent c-Jun phosphorylation have also been described in human NASH; 32 however, higher c-Jun abundance in NAFLD has not been described so far in NAFLD models or human NAFLD tissues.
Expression of c-Jun in Human NAFLD
Notably, we observed also in human NAFLD tissue significantly enhanced c-Jun mRNA expression compared with normal liver tissue (Supplementary Figure 2) . Furthermore, we applied TMA technology and immunohistochemistry (IH) to assess c-Jun expression in human liver tissue with different degree of steatosis and inflammation. IH was informative in 110 cases. The intensity of the immunohistochemical c-Jun signal revealed significant differences in individual patients, and thus, was systematically categorized into absent (score ¼ 0), weak (score ¼ 1) or strong (score ¼ 2) staining. Representative examples of steatotic liver tissues with different c-Jun staining intensities are depicted in 44 Accordingly, we observed significant correlation between the inflammatory score and the intensity of cytoplasmatic c-Jun expression (Table 3) , while no association was found with age, gender, BMI class or ballooning of hepatocytes. However and surprisingly, we observed a remarkable correlation between the grade of hepatic steatosis and cytoplasmatic c-Jun staining ( Figure 7c and Table 3 ). This finding indicates that hepatic steatosis leads to enhanced c-Jun levels independent of the presence of hepatic inflammation.
In line with this, we observed increased c-Jun expression in an in vitro model of hepatic steatosis, which we have recently described. 11 Supplementation of increasing doses of FFAs to Figure 3A) . It is noteworthy that this increase was flanked by increased expression of the proinflammatory cytokine interleukin 8 (IL-8; Figure 7g and Supplementary Figure 3B) . Furthermore, we performed the according in vitro experiments with primary murine hepatocytes and found a similar induction of c-Jun expression in response to lipid accumulation as observed in PHHs indicating that this mechanism is not species dependent (data not shown). Transient transfection with siRNA against c-Jun significantly inhibited the FFAinduced c-Jun expression compared with cells transfected with control siRNA (Figure 7h ). Moreover, inhibition of c-Jun impaired FFA-induced IL-8 expression (Figure 7i ). Together, these findings suggest that steatosis induced c-Jun expression promotes inflammation in NAFLD.
DISCUSSION
We developed a new murine NASH model by feeding a diet that reproduces the nutritional situation of most NAFLD patients in Western countries, that is, chronic high caloric intake rich in saturated fats, cholesterol and fructose. After 12 weeks of feeding, this diet mice developed obesity and diabetes, key components of the metabolic syndrome and known factors driving human NAFLD development and progression. Furthermore, histological analysis revealed steatohepatitis that closely resembles human NASH. Importantly, ND-feeding also induced fibrosis, the most critical pathogenic factor for morbidity and mortality of NAFLD patients. Expression analysis revealed marked alterations in genes related to metabolic processes, transportation, signal transduction and oxidation reduction in the murine NASH model. AP-1 appeared as crucial transcriptional regulator of these alterations. Saturated FFAs activate this proinflammatory transcription factor in hepatocytes, 45 and enhanced AP-1 activation has been demonstrated in obese patients with NASH. 46 AP-1 is a homo-or heterodimer consisting of proteins belonging to the c-Jun, c-Fos, ATF and JDP families, 47 with c-Jun being the best-characterized AP-1 component. The nuclear import of c-Jun is mediated by multiple mechanisms 48, 49 and nuclear c-Jun levels correlate with AP-1 target gene activity. 49 This further increases c-Jun protein abundance, as the jun proto-oncogene itself is activated by AP-1 in the manner of a positive auto-regulatory loop. 44 The activity of c-Jun/AP-1 is markedly enhanced by phosphorylation of the transcriptional activation domain by JNKs. 50 Sustained activation of the JNK pathway mediates the development and progression of experimental diet-induced NAFLD. 51 Still, the role of different JNK-isoforms in NAFLD is not completely understood and it is becoming more and more evident that they may exhibit diverse effects in various cell types. 8, 52 Apart from boosting c-Jun/AP-1 activity, JNK activation can also phosphorylate insulin receptor substrates (IRS)-1 and -2, which may lead to insulin resistance by blocking insulin receptor signal transduction. 5 This is one mechanism by which fructose, regarded as a mostly insulin-independent sugar, can induce insulin resistance because of its JNKactivating properties. 8 Further inducers of JNK activity are ROS, which are also known to have a role in NAFLD progression. 36 In our model as well as in human NASH, ROS may arise from excessive b-oxidation of FFA, from mitochondrial damage caused by free cholesterol accumulation and crystallization, 5 and from extensive activation of the NAD(P)H oxidase enzyme complex. The latter is activated by the adipokine leptin, 53 and the levels of this adipokine are increased in our NASH model. Apart from the fact that JNK enhances c-Jun/AP-1 activity, Schreck et al 49 demonstrated that the c-Jun itself promotes nuclear accumulation of JNK, further propelling AP-1 transcriptional activity. These various positive cross-and auto-regulatory loops may be Transcription factor motives significant at the 0.05 level are shown. Interestingly, three motives of AP1 (labeled bold) are significant. The column 'Gene set size' holds the number of genes with the respective transcription factorbinding site (TFBS) represented on the array, the column 'Expected hits' depicts the number of genes with a TFBS expected by chance and the column 'Observed hits' the observed number of differentially expressed genes with a TFBS for this factor. 'P-value' denotes the raw P-value, and 'FDR' the q-value. c-Jun in NAFLD C Dorn et al co-responsible for the progression from simple steatosis to NASH. Factors that lead to a manifest derangement of the JNK/c-Jun/AP-1 regulatory system, or mechanisms by which the vicious circle of positive JNK/c-Jun/AP-1 auto-regulation could be interrupted, represent promising targets to interfere with NASH development and progression. Interestingly, in neurons JNK-mediated phosphorylation was shown to accelerate c-Jun degradation by allowing its recognition by the E3 ligase Fbw7-containing Skp/Cullin/F-box protein complex (SCFFbw7). 54 Furthermore, activation of the JNK pathway promoted degradation of c-Jun (and JunB) through phosphorylation-dependent activation of the E3 ligase Itch in stimulated T cells. 55 Analysis of these or similar mechanisms in hepatocytes are still elusive. It is important to distinguish interruption of hyperactivation of hepatocellular JNK/c-Jun/ AP-1 signaling from a complete abolishment of JNK in hepatocytes, as mice with specific ablation of Jnk1 in hepatocytes surprisingly exhibit glucose intolerance, insulin resistance and hepatic steatosis. 9 Moreover, we have shown that c-Jun abundance is a critical pathogenic factor in malignant melanoma independent of JNK activation. 56 There, c-Jun levels are regulated at the post-transcriptional level by micro RNA (miR) 125b. 57 Interestingly, miR-125b has also been described as a tumor suppressor in hepatocellular carcinoma, 58 but its expression and function in NAFLD are unknown. Further studies are also required to unravel the mechanisms causing increased c-Jun levels in NAFLD.
In conclusion, our novel dietary murine NASH model induces important pathomechanisms also found in human NASH and indicates c-Jun/AP-1 activation as critical regulator of hepatic alterations. We newly discovered increased hepatic c-Jun expression in this model and confirmed this observation in NAFLD patients where we detected c-Jun abundance even in simple steatosis. It appears likely that higher c-Jun levels facilitate NASH development and progression. Thus, c-Jun may serve as prognostic marker and appears as attractive therapeutic target to prevent the development and progression of NASH. c-Jun in NAFLD C Dorn et al
